<DOC>
	<DOCNO>NCT01369082</DOCNO>
	<brief_summary>The purpose study provide patient receive least one islet transplant previous participant Clinical Islet Transplantation Consortium ( CIT ) clinical trial maintenance immunosuppressive medication collect information safety medication islet function .</brief_summary>
	<brief_title>Extended Follow-Up After Islet Transplantation T1D</brief_title>
	<detailed_description>After islet-cell transplantation CIT studies* , subject receives maintenance immunosuppressive medication . The purpose protocol collect additional follow-up safety efficacy CIT subject graft function completion CIT parent study . It expect subject retain measurable islet function , islet-alone study , continue receive immunosuppressive medication time complete CIT parent study . *CIT parent study : CIT02 ( NCT00464555 ) , CIT03 ( NCT00434850 ) , CIT04 ( NCT00468403 ) , CIT05 ( NCT00468442 ) , CIT06 ( NCT00468117 ) , CIT07 ( NCT00434811 )</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Subjects receive islet transplant participation follow Clinical Islet Transplantation ( CIT ) parent study : CIT02 ( NCT00464555 ) , CIT03 ( NCT00434850 ) , CIT04 ( NCT00468403 ) , CIT05 ( NCT00468442 ) , CIT06 ( NCT00468117 ) , CIT07 ( NCT00434811 ) A function pancreatic islet graft ( e.g. , absence graft failure define parent study ) require immunosuppression Willingness participant continue use approve method contraception 4 month study participation Ability provide write informed consent Resident United States America Documentation existence lack health insurance coverage whether immunosuppressant cover . For female subjectsPositive pregnancy test , presently breastfeed , unwillingness use effective contraceptive measure duration study 4 month discontinuation For male subjectsIntent procreate duration study within 4 month discontinuation unwillingness use effective measure contraception . Oral contraceptive , Norplant® , DepoProvera® , barrier device spermicide acceptable contraceptive method ; condom use alone acceptable . Received islet transplant nonCIT research study Any medical condition , opinion investigator , interfere safe participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>islet allograft function</keyword>
	<keyword>c-peptide production</keyword>
	<keyword>maintenance immunosuppressive medication</keyword>
</DOC>